Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 60.50
+2.30 (3.95%)
At close: Feb 10, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.5 billion as of February 12, 2026. Its market cap has increased by 30.11% in one year.
Market Cap
6.50B
Enterprise Value
10.52B
Revenue
9.52B
Ranking
n/a
PE Ratio
12.13
Stock Price
60.50
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.50B, an increase of 129.17%. That is a compound annual growth rate of 28.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 6.50B | 16.57% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 24.72B |
| The ACME Laboratories | 16.12B |
| The IBN SINA Pharmaceutical Industry | 10.82B |
| Asiatic Laboratories | 8.37B |
| Orion Pharma | 6.95B |
| Techno Drugs | 4.18B |
| Ambee Pharmaceuticals | 1.88B |
| Pharma Aids | 1.84B |